Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Organon Q4 Adjusted EPS $0.88 Beats $0.83 Estimate, Sales $1.60B Beat $1.55B Estimate

Author: Benzinga Newsdesk | February 15, 2024 08:32am
Organon (NYSE:OGN) reported quarterly earnings of $0.88 per share which beat the analyst consensus estimate of $0.83 by 6.02 percent. This is a 8.64 percent increase over earnings of $0.81 per share from the same period last year. The company reported quarterly sales of $1.60 billion which beat the analyst consensus estimate of $1.55 billion by 3.10 percent. This is a 7.61 percent increase over sales of $1.49 billion the same period last year.

Posted In: OGN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist